Dynavax Technologies | Kontanter Og Tilsvarende

Cash And Equivalent Endring Dato
AbbVie USD 18.07B 4.78B 2024-03
Adma Biologics USD 45.32M 6.03M 2024-03
Amgen USD 9.71B 1.24B 2024-03
AstraZeneca USD 7.84B 2B 2024-03
Biogen USD 1.07B 24.5M 2024-03
BioMarin Pharmaceutical USD 747M 8.13M 2024-03
Bristol-Myers Squibb USD 9.33B 2.13B 2024-03
Dynavax Technologies USD 132.03M 18.25M 2024-03
Gilead Sciences USD 4.72B 3.71B 2024-03
Glaxosmithkline GBP 2.79B 146M 2024-03
Merck USD 5.58B 3.03B 2024-03
Neurocrine Biosciences USD 396.3M 102.6M 2024-03
Novartis USD 9.47B 3.92B 2024-03
Pfizer USD 719M 2.43B 2024-03
Regeneron Pharmaceuticals USD 2.6B 13.64B 2024-03
Roche Holding CHF 5.38B 1.66B 2023-12
Sarepta Therapeutics USD 427.29M 114.64M 2024-03
TG Therapeutics USD 75.48M 142.03M 2024-03
Vertex Pharmaceuticals USD 9.16B 1.95B 2024-03



Dynavax Technologies Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.